CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist
  • 144.44
  • +5.83+4.21%
Market Closed Apr 26 15:00 CST
57.92BMarket Cap13.19P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sichuan Biokin Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 27, 2024

Revenue(YoY)

5.46B

+4325.45%
EPS(YoY)

12.48

+3071.43%
Analyst Rating

Strong Buy

Apr 28, 2024

Sichuan Biokin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.218B--
--2024/FY-- / 6.134B--
--2023/FY561.871M / 562.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.218B--
--2024/FY-- / 6.134B--
--2023/FY561.871M / 562.000M--

Sichuan Biokin Pharmaceutical Earnings Reports

  • Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2024 First Quarter Report

    Apr 27 00:00

  • Summary of the 2023 Annual Report of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.

    Apr 27 00:00

  • Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2023 Annual Report

    Apr 27 00:00

  • Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2023 Annual Results Express Announcement

    Feb 24 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg